reduce arbitrarily the concentration of each drug to a level where neither one alone was completely inhibitory. Very commonly one could as readily effect a complete inhibition of growth by simply increasing the concentration of either drug. The ultimate justification for combined therapy then should be based on a combined effect that is greater than that achieved by the safe maxmum dosage of either drug alone. One rationale that appeared to justify combined therapy in infections due to a single agent was the inhibition of the development of drug resistance (Klein and Kalter, 1946; Klein and Kimmelman, 1947) . The concept may be stated as follows: All bacterial populations show variation in the susceptibility of their individual cells to a given concentration of an antibiotic (Demerec, 1945;  Klein, 1947) . At partially inhibitory concentrations of a single drug the surviving bacteria represent a selection of the most resistant cells in the culture. In order to inhibit completely these small numbers of resistant cells an extremely large increase in the antibiotic concentration frequently is needed, and occasionally as in the case of strepto-1 Presented at the 52nd General Meeting of the Society of American Bacteriologists, April 27-May 1, 1952, Boston, Massachusetts. mycin a few highly resistant celLs might be present that are not inhibited by a maximum concentration of the drug (Klein and Kimmelman, 1946) . A most reasonable method for effecting a more complete inhibition of growth and preventing the development of resistant cells is the addition of a second antibiotic having a different mode of action as indicated by the inhibition of the cells resistant to the first antibiotic. That combined drugs in fact inhibited the development of resistant cells was demonstrated for penicillin and streptomycin in vitro (Klein and Oimmelman, 1947) and subsequently considered to occur clinically (Robbins and Tompsett, 1949; Tempel et al., 1950; Friedman et al., 1952) . Combinations of sulfonamides, penicillin, streptomycin, and p-aminosalicylic acid have been used quite extensively, and apparently the results have been considered satisfactory though controlled clinical studies on combined therapy are quite limited. One reservation concerning the use of combined drugs was pointed out in an earlier publication (Klein and Kalter, 1946 ; see also Chain and Duthie, 1945) . It was shown that under certain conditions antagonism, as demonstrated by a significant inhibition of the bactericidal and lytic action of penicillin by an added sulfonamide, could be shown to occur in vitro. However, since the observed effect was merely an inhibition of the initial (24 hours) action of the penicillin while the ultimate effect (72 hours) was synergistic, this antagonism was considered only of minor importance. More recently the subject of bacterial antagonism has received considerable emphasis, and several workers have pointed out that in addition to the antagonism observed with penicillin and sulfonamides, aureomycin, terramycin, and chloromycetin antagonized the action of penicillin and streptomycin (Lankford and Lacy, 1949; Gunnison et al., 1950; Jawetz and Gunnison, 1950; Bliss et al., 1952) . The reported phenomena of antagonism have varied with the test bacterial species in a rather unpredictable fashion. With the establishment of the phenomenon in vitro, and indications that it occurs experimentally in vio and probably under limited conditions clinically (Lepper and Dowling, 1951) considerable uncertainty has arisen as to the indications for combined therapy. On the basis of the available data one cannot predict readily under what conditions synergism or antagonism will occur. It should be noted that the indication for combined therapy in infections due to a single infectious agent was based on the requirement that bacteria show a significant increase in reistance to a chemotherapeutic agent. There has never been formulated any rationale for combined thrapy due to infectious agents that do not become resistant promptly (e.g. pneumococci, group A streptococci). This distinction between the efficacy of combined therapy in infections where resistance is or is not a factor has not been clearly defined and in the present work we will point out that the combined effect of two drugs differs markediy depending upon the pattern of bacterial resistance. Our conclusions will be based upon an extension of our initial concept that when bacteria become resistant, synergism is related to the inhibition by an added drug of resistant cells surviving the action of the first antibiotic; in the absence of a prompt development of resistant cells synergism commonly does not occur and a moderate degree of antagonism frequently may be observed.
MATERIALS AND METHODS
Procedure for evaluating the combined action of two drugs. The action of ten antibiotics in various combinations (table 1) Procedure for determining the increase in drug resistance of the test bacterial species. Portions of the plain broth control and the antibiotic broth cultures from each of the two drugs being tested were removed after 24 and 48 hours' incubation at 37 C. The cells were spun down and resuspended in saline. They were adjusted to a standard turbidity in the colorimeter and reasayed for any change in resistance by comparing the growth rate in antibiotic broth of the original sensitive strain (broth control) with that of the culture previously grown (for 24 or 48 hours) in the antibiotic broth. Bacteria grown in antibiotic A were reassayed not only against antibiotic A for any change in resistance but were assayed for cross resistance against antibiotic B. Likewise cells grown in antibiotic B were assayed against both antibiotics B and A. Most commonly the pattern of resistance for a given species against a single antibiotic was constant though occasionally (with penicillin or streptomycin) the bacteria after the initial 24 hours' growth might show upon reassay no increase in resistance, or even a slight increase in susceptibility, while after 48 hours' growth they might show upon reassay an increase in resistance. The degree of resistance showed some variation with the initial test concentration of antibiotic in which the organism was grown. However, when we have recorded no increase in resistance, none was observed at any concentration. they tend to form a distinct pattern with neither synergism nor antagonism occurring to a significant degree. The results with these latter combinations will be considered in greater detail below, and it will suffice here to state that bacteria grown in these antibiotics (particularly aureomycin and terramycin) show cross resistance. It may be noted that though certain pairs (e.g., penicillin and streptomycin) tend to give a relatively high incidence of synergistic and additive effects other combinations tend to give a relatively high incidence of interfering and antagonistic effects, e.g., streptomycin combined with either aureomycin, terramycin, or chloromycetin. However, no combination invariably gave a consistent response against all 11 species. A particular combination was neither synergistic nor antagonistic against all species; some property of the test organism modified the pattern of the combined effect.
One property we have found of importance in determining the nature of the combined effect was the rate of development of resistance by the bacteria to the test antibiotics. Summary of correlation between dru resistance and synergistic and antagonistic reaction. Table 7 summarizes all of the synergistic and antagonistic readings obtained with the 11 species against the 10 antibiotic combinations and relates the data to the pattern of resistance. For simplicity of statement we have not included the additive and interference readings though inclusion of these resWults would not have modified the final interpretations. In an attempt to express quantitatively the degree of bacterial resistance we have subdivided the resistance reactions into 4 groups. As shown in table 7 when the development of resistance was of a high order, i.e., the cells became promptly resistant to both antibiotics (group 1), the effect was never antagonistic and the incidence of synergistic reactions was high. With a reduction in the intensity of resistance there was a reduction in the incidence of synergistic reactions. Finally when the bacteria did not become resistant to either antibiotic (group 4), synergism rarely occurred and antagonism appeared as a frequent final effect. It should be noted again that (as shown in table 1) Though several factors may be involved only one will be considered. In a previous publication (Klein and Kalter, 1946) on the combined action of penicillin and the sulfonamides against S. aureus, it was pointed out that if one adds a sulfonamide to the S. aureus culture followed in a few hours by penicillin, the sulfonamide markedly inhibited the initial bactericidal and lytic action of the penicillin. In the present work we have observed also that penicillin was markedly lytic against S. aureus and this lytic action was inhibited by the addition of aureomycin, terramycin, chloromycetin, and low concentrations of streptomycin. That aureomycin, terramycin, and chloromycetin slowed down the rate of killing of penicillin and streptomycin also has been pointed out previously by others (Jawetz and Gunnison, 1951) . The interpretation we initially suggested for the antagonistic action of the sulfonamide upon penicillin was as follows. Penicillin was most effective in the presence of actively dividing cells; therefore a bacteriostatic agent such as the sulfonamides antagonized the action of penicillin by inhibiting the multiplication of the susceptible cells (see also Chain and Duthie, 1945) . As further evidence for this conclusion it was pointed out that if the penicillin were added before the sulfonamide there was no antagonism. Of particular interest, however, was the observation that antagonism occurred early, within the first 24 hours, and was overcome subsequently, for the combination of penicillin and the sulfonamides against S. aureus was ultimately (at 72 hours) more effective than either drug alone. Hence there was a dual response; an initial antagonism followed by synergism.
In considering possible mechanism for this dual response it is important to note that this ultimate synergism was associated with the fact that the S. aureus became resistant to penicillin and the sulfonamide inhibited the multiplication of these resistant cells. However, if one were working with a strain that did not become resistant, the initial antagonism might have been maintained and the ultimate effect may have been antagonistic rather than synergistic. The following interpretation is suggested to explain the reactions of both antagonism and synergism observed with the same antibiotic combinations tested against different bacterial species. When one combines 2 drugs against a bacterial species that does not become resistant promptly, there may be a slowing up of the initial rapid killing or lytic action of penicillin and streptomycin by an added bacteriostatic antibiotic; under such conditions some measure of antagonism may be observed. However, when the test species is one in which resistant celLs promptly develop, the inhibition of these resistant cells by an added drug represents a counter reaction that tends to overcome any initial antagonism that may occur. Therefore, depending upon the extent of this 'counter effect', namely the rapidity and degree of resistance developed by the bacteria (and subsequently inhibited by the second antibiotic), precisely the same drug combination may show a combined effect ranging from antagonism (associated with no development of resistance) through an interference, additive, or synergistic effect (associated with a prompt development of resistance).
Jawetz and his collaborators in discussing possible mechanisms of synergism and antagonism did not consider bacterial resistance as a factor in their combined effect (Jawetz and Gunnison, 1952) . However, their studies differed from ours in that they were carried out at concentrations of drugs that were completely inhibitory and the effect they measured was essentially the rate of destruction of the celLs in the initial inoculum. There was only limited opportunity for significant bacterial multiplication in their system hence 462 [voL. 65 on October 19, 2017 by guest http://jb.asm.org/ Downloaded from ANTIBIOTIC SYNERGISM AND ANTAGONISM little chance for the emergence and subsequent selection of resistant variants. Our studies were all carried out at partially inhibitory concentrations of the antibiotics which permitted some growth and the emergence of resistant cells. For example, Gunnison et al. (1950) A most useful guide to combined therapy is a knowledge of the rate of development of resistance of the infectious agent to the antibiotics. If, for example, one is treating an infection and the emergence of resistant cells is a common feature of the clinical course of the disease, combined therapy is indicated. The combination of streptomycin and p-aminosalicylic acid in the treatment of tuberculosis may be cited as an example. Here the infectious agent can develop resistance to each of the chemotherapeutic agents, but since they have separate modes of action they are each capable of inhibiting the resistant cells of the other. On the other hand if one is treating an infection which is acute and in which resistant celLs do not commonly arise, combined therapy is not indicated and is probably contraindicated where there is available a single effective drug. Under such conditions increasing the concentration of the one effective drug rather than attempting to increase the therapeutic action by adding another drug would appear to be the preferred method when toxicity is not a limiting factor. Experimentally the antagonism observed with a group A streptococcus in mice (Speck et al., 1951) may be cited as an example. As we have shown, and as is generally recognized, the group A streptococcus is an organism that does not become resistant readily, hence in an acute infection a simple additive or antagonistic effect might be expected. Bliss, Warth, and Long (1952) found antagonism only irregularly with a group A streptococcus infection while Ahern, Burnell, and Kirby (1952) reported that when the infection was less acute and therapy was prolonged no antagonism was observed. However, synergism was not observed by any of the workers.
The antagonism noted by Lepper and Dowling (1941) in the treatment of pneumococcal meningitis may be cited as a clinical example of antagonism. In this infection the orgaism rarely becomes resistant to penicillin or aureomycin.
There are then no indications for combined therapy, and as the authors reported, aureomycin added to the penicillin apparently increased the mortality rate of the infection.
It should be emphasized that the antagonism observed in titro is of a moderate nature. There may be a quantitative reduction in the inhibitory activity of combined drugs but never a complete elimination of the inhibitory activity. The reported antagonism observed in pneumococcal meningitis probably represents an extreme clinical situation, for in the rapidly fatal pneumococcal meningitis even a moderate slowing up in the rate of killing by penicillin may be sufficient to cause an increase in mortality. A similar slowing up in the rate of action of penicillin probably would not be particularly significant in most infections, and further when two potentially antagonistic drugs are used they may be present in excess and offer a large margin of safety.
We may conclude that combined therapy probably is indicated in an infection in which resistance develops promptly or in chronic infections in which resistant cells ultimately develop. The combined drugs must of course have some degree of activity against the bacteria and have separate modes of action. In acute infections caused by bacteria that do not become rapidly resistant (pneumococcal infections, infections due to group A streptococci, etc.), combined therapy is not indicated and probably is contraindicated when there is available a single effective drug. Though antagonism may occur in this latter category and in the case of pneumococcal meningitis has been reported to be clinically significant, the importance of antagonism in other clinical infections remains to be determined.
SUMARY
The in vitro combination of penicillin and streptomycin with aureomycin, terramycin, or chloromycetin gave a combined effect that varied from synergism to antagonism depending upon the bacterial strain tested. With variation in the test strain, precisely the same drug combination might give either an antagonistic or synergistic response.
The property of the test strain found associated with synergism or antagonism was the rate at which the organism became resistant to each of the antibiotics. When bacteria promptly became resistant after growth in each of two antibiotics, the combination of the two drugs resulted in a combined effect that was frequently synergistic and never antagonistic.
When the bacteria did not become resistant promptly to either antibiotic, synergism rarely occurred and antagonism was observed frequently. Our data though showing the correlation between resistance and antagonism are not an explanation of antagonism. One interpretation of antagonism is discussed.
On the basis of the present data the clinical indications for combined therapy are discussed.
